Thesis
- 03/05/2023
- Series A
- $8,400,000
Thesis is the world’s first personalized brain supplement brand. We understand that everyone's brains are unique and cognitive demands for daily tasks are constantly changing.
Our nootropics are a powerful alternative to stimulants, providing similar benefits, minus the jitters, crash, and side effects.
Powered by the world’s largest data set on the efficacy of nootropics and advised by neuroscientists from Yale, Penn, and MIT, Thesis quickly and safely delivers increased focus, creativity, energy, and memory in capsule form.
- Industry Wellness and Fitness Services
- Website https://takethesis.com/
- LinkedIn https://www.linkedin.com/company/takethesis/
Related People
Dan FreedCo Founder
Grew up in Los Angeles, worked internationally for a decade, studied at INSEAD + Yale. I’m now in New York building Thesis: the world’s only personalized brain supplements (nootropics) company. Nootropics have had a huge impact on my life. They’ve helped me go from a sandwich artist at Subway to cooking in a three Michelin star restaurant, and from being a high school drop-out to obtaining degrees in world class universities. We believe that everyone should have access to nootropics so they can realize their full potential.
Thesis has helped thousands of people who struggle with focus, attention, writer’s block, and countless other mental barriers that affect their brains’ performance. We tested over a hundred ingredients on thousands of people and our products produce measurable results that demonstrate the effectiveness and safety of our product. We’ve worked with a team of neuroscientists from MIT, Penn, and Yale to create the most effective blend of supplements customized for you.
Here's my story: https://www.youtube.com/watch?v=WJcQIxxf6Mo
I'm interested in speaking opportunities, interviews and podcasts. Get in touch: dan@takethesis.com.